The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declinesWallstreetcn·Mar 19 at 06:30 AM300016-2.09%688136-4.38%
The leading stocks in the brain-computer interface concept continue to strengthen, with 6 stocks receiving institutional research 5 times or moreWallstreetcn·Aug 16, 2025 at 11:10 AM300007-3.31%300753-3.43%
